Critical Care

official impact factor 4.60

Highly Access Review

Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians

Ana L Huerta-Alardín1, Joseph Varon2* and Paul E Marik3

Author Affiliations

1 Universidad Autónoma de Tamaulipas School of Medicine, Tampico, México

2 The University of Texas Health Science Center and St Luke's Episcopal Hospital, Houston, Texas, USA

3 Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA

For all author emails, please log on.

Critical Care 2005, 9:158-169 doi:10.1186/cc2978

Published: 20 October 2004

Abstract

Rhabdomyolysis ranges from an asymptomatic illness with elevation in the creatine kinase level to a life-threatening condition associated with extreme elevations in creatine kinase, electrolyte imbalances, acute renal failure and disseminated intravascular coagulation. Muscular trauma is the most common cause of rhabdomyolysis. Less common causes include muscle enzyme deficiencies, electrolyte abnormalities, infectious causes, drugs, toxins and endocrinopathies. Weakness, myalgia and tea-colored urine are the main clinical manifestations. The most sensitive laboratory finding of muscle injury is an elevated plasma creatine kinase level. The management of patients with rhabdomyolysis includes early vigorous hydration.

Keywords:
creatinine kinase; muscle damage; myoglobin; myoglobinuria; renal failure; rhabdomyolysis